Auto Stem Cell Transplant for Lymphoma Patients

NCT03125642 PHASE2 RECRUITING

This is a phase II study of autologous transplant for patients with Hodgkin (HL) and non-Hodgkin lymphomas (NHL) including those who are HIV positive.

Details

Lead sponsor	Masonic Cancer Center, University of Minnesota
Phase	PHASE2
Status	RECRUITING
Enrolment	150
Start date	Thu Apr 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Apr 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Non-Hodgkin Lymphoma
• Hodgkin Lymphoma

Interventions

• Etoposide
• BCNU
• AraC
• Melphalan
• Peripheral blood stem cell transplantation
• G-CSF
• Cyclophosphamide
• Total Body Irradiation

Countries

United States